My top #ASCO24 #LCSM abstracts!
(Nine, not ten, because irs Saturday)

Top 10 Lung

1.Osimertinib (osi) after definitive chemoradiotherapy (CRT) in patients (pts) with unresectable stage (stg) III epidermal growth factor receptor-mutated (EGFRm) NSCLC: Primary results of the

Congratulations Ivy Riano, M.D.. Very inspiring.

Looking forward to seeing in person. Inimfon Jackson ASCO TECAG

I am looking forward to this talk next week Thursday.

ASCO Survey Finds Oncologists’ Well-Being Worsened Over the Past Decade—but Steps Can Be Taken to Mitigate Burnout: A Conversation With Fay J. Hlubocky, PhD, MA, FASCO ascopost.com/issues/may-10-… Fay Hlubocky PhD MA FASCO ASCO #oncology #burnout

Thank you for having me. I loved talking about this field I am very passionate about. Tulsi Jose, MD Beatrice Torere, MD

Thrilled to announce I am one of the recipients of the ASH RTAF #ASHAwards ! A huge thank you to mentors Wendy Stock Faubert Mariam Nawas and institutional support from University of Chicago Hematology/Oncology.

Looking forward to this tomorrow. Tulsi Jose, MD Beatrice Torere, MD

The research team is dedicated to support your success at the ASCO 2024. If you are presenting a poster or having an oral session, please fill out docs.google.com/spreadsheets/d…
or email Adeleke ([email protected]).Nazli Dizman Arya Roy Karun Neupane, MD Charles Jiang MD, MPH

Best of ASCO for trainees and early career physicians!

Next week!!

If you haven't registered yet, make sure to check out the 27th UChicagoCancerCenter Developmental Therapeutics Symposium co-directed by Toyosi Odenike & Walter Stadler! Learn more at cme.uchicago.edu/CDTS2024

Congratulations!

Join us on May 11 to discuss the first 6 months of fellowship. ASCO TECAG Hem-Onc Fellows Network. I am looking forward to having a good discussion with Beatrice Torere, MD.

Out in Journal of Clinical Oncology NECTIN4 Amplification predicts Enfortumab Vedotin response in Urothelial Cancer #mUC
💊 96% response rate to EV therapy in amplified cases vs 32% in others (P < .001).
➡️Perhaps we need to look deeper than IHC for other ADCs too? 🤔 ascopubs.org/doi/full/10.12…

Congratulations Nabiel Mir MBBS. Well done on your important work in #Gerionc University of Chicago Hem/Onc Fellows

Congratulations Coral Olazagasti, MD

The opportunity to be an oncologist is unmatched and I am grateful to be a part of my patients’ lives in such a unique way.

Excited to announce! 🎉 Mark your calendars for the ASCO #IMG Community of Practice Meeting at #ASCO24
🕰️Fri 5/31, 4-6 PM CST at Room S103 McCormick Place.
Looking forward to coming together to celebrate IMGs and discuss ways to support each other. Join us!
Ziad Bakouny, MD, MSc

So well deserved. Congratulations Inimfon Jackson ASCO TECAG

excited to share an episode of the Journal of Clinical Oncology Podcast where I discuss updates of the LYSA and RESORT trials; these long-term outcomes and updates from these studies cement the standard set out by these studies for MCL and FL and continue to do so! ASCO

sites.libsyn.com/58526/jco-arti…